Shai Lankry
Chief Financial Officer @Gamida Cell Inc
Signup · Get unlimited contacts
WORK HISTORY
Chief Financial Officer @Gamida Cell Inc
Boston, MA, US
Gamida Cell is pioneering a diverse immunotherapy pipeline of potentially curative cell therapies for patients with solid tumor and blood cancers and other serious blood diseases. Gamida applies its proprietary expansion platform leveraging the properties of NAM to allogeneic cell sources including umbilical cord blood-derived cells and NK cells to create therapies with potential to redefine standards of care. These include omidubicel, an investigational product with potential as a life-saving alternative for patients in need of bone marrow transplant, and a line of modified and unmodified NAM-enabled NK cells targeted at solid tumor and hematological malignancies.
EDUCATION
Tel Aviv University
Master of Business Administration (M.B.A.), Finance
ABOUT SHAI LANKRY
Biotechnology Executive with over 20 years of experience in Corporate Finance, Business Development, Investor Relations and Executive Leadership. Drive value creation for innovative companies through strategic planning, capital raising and business development activities. Established Life science network of relationships spanning biotech/pharma industry, healthcare institutional investors, investment bankers, and equity research analysts.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.